Get started
Author

A. N. Makoveeva

Observed names: A N Makoveeva, A.N. Makoveeva, А. N. Vernokhaeva, Маковеева А. Н.
ORCID: 0000-0002-9111-8738
Observed ORCID: 0000-0002-9111-8738
OpenAlex ID: A5083458039
Prospective in-hospital registry of patients with suspected or documented COVID-19 infection and community-acquired pneumonia (TARGET-VIP): characteristics of patients and assessment of in-hospital outcomes
2020 · O. M. Drapkina, O. E. Karpov, et al. · CARDIOVASCULAR THERAPY AND PREVENTION · 24
PDF
Experience of creating and the first results of the prospective hospital registry of patients with suspected or confirmed coronavirus infection (COVID-19) and community-acquired pneumonia (TARGET-VIP)
2020 · O.M. Drapkina, O.E. Karpov, et al. · Russian Journal of Preventive Medicine · 20
Long-term outcomes in patients after COVID-19: data from the TARGET-VIP registry
2022 · M. M. Lukyanov, N. P. Kutishenko, et al. · Russian Journal of Cardiology · 19
PDF
Combination of Atrial Fibrillation and Coronary Heart Disease in Patients in Clinical Practice: Comorbidities, Pharmacotherapy and Outcomes (Data from the REСVASA Registries)
2021 · M. M. Loukianov, S. Yu. Martsevich, et al. · Rational Pharmacotherapy in Cardiology · 12
Early cardiovascular multimorbidity in out- and in-patient care: age characteristics and medication therapy (data from the REKVAZA and REKVAZA-CLINIC registries)
2020 · E. Yu. Andreenko, M. M. Lukyanov, et al. · CARDIOVASCULAR THERAPY AND PREVENTION · 12
PDF
Patients with a Combination of Atrial Fibrillation and Chronic Heart Failure in Clinical Practice: Comorbidities, Drug Treatment and Outcomes
2022 · M. M. Loukianov, S. Yu. Martsevich, et al. · Rational Pharmacotherapy in Cardiology · 9
PDF
Two-year outcomes in patients after hospitalization for COVID-19: data from the TARGET-VIP registry
2023 · M. M. Lukyanov, E. Yu. Andreenko, et al. · CARDIOVASCULAR THERAPY AND PREVENTION · 7
PDF
Clinical and Anamnestic Characteristics, Cardiovascular Pharmacotherapy and Long-term Outcomes in Multimorbid Patients after COVID-19
2022 · A. A. Smirnov, M. M. Loukianov, et al. · Rational Pharmacotherapy in Cardiology · 7
PDF
Cardiomyopathy in the Friedreich Ataxia: Clinical Presentation and Diagnostics of Complications
2017 · Е. I. Fomicheva, R. P. Myasnikov, et al. · Russian Journal of Cardiology · 5
PDF
Long-term outcomes in patients with cardiovascular multimorbidity suffered from COVID-19: two-year observation
2023 · A.A. Smirnov, M.M. Loukianov, et al. · Russian Journal of Preventive Medicine · 4
Long-term follow-up of patients after COVID-19: adherence to SARS-CoV-2 vaccination and immune status
2022 · M.M. Loukianov, E.Yu. Andreenko, et al. · Russian Journal of Preventive Medicine · 4
Patients with Premature Cardiovascular Diseases in Ambulatory Practice: Demographic Characteristics, Risk Factors and Adherence to the Medical Therapy (Data of RECVASA Registry)
2020 · E. Yu. Andreenkо, M. M. Loukianov, et al. · Rational Pharmacotherapy in Cardiology · 4
PDF
Long-term outcomes in patients after hospital treatment for COVID-19 (three-year follow-up data)
2024 · M.M. Loukianov, S.Yu. Martsevich, et al. · Russian Journal of Preventive Medicine · 3
Prehospital Period in Patients with COVID-19: Cardiovascular Comorbidity and Pharmacotherapy During the First Epidemic Wave (Hospital Registry Data)
2022 · S. Yu. Martsevich, M. M. Lukyanov, et al. · Rational Pharmacotherapy in Cardiology · 3
PDF
Dynamics of age characteristics and prevalence of concomitant cardiovascular and non-sardiovascular diseases in patients hospitalized with COVID-19 during epidemic wave: data from TARGET-VIP registry
2022 · M. M. Lukyanov, S. Yu. Martsevich, et al. · CARDIOVASCULAR THERAPY AND PREVENTION · 2
PDF
Detection rate and characteristics of heart failure, depending on the diagnostic criteria in COVID-19 survivors one year after hospitalization
2023 · Yu. V. Mareev, M. M. Lukyanov, et al. · CARDIOVASCULAR THERAPY AND PREVENTION · 1
PDF
Medical treatment of patients with cardiovascular diseases during the first year after hospitalization for COVID-19
2023 · N. P. Kutishenko, M. M. Lukyanov, et al. · CARDIOVASCULAR THERAPY AND PREVENTION · 1
PDF
Prehospital period in patients with COVID-19 and community acquired pneumonia: age characteristics, cardiovascular comorbidity and pharmacotherapy during epidemic wave (the data of hospital registry)
2021 · M Lukiyanov, S Y Martsevich, et al. · European Heart Journal
PDF
P5352The main characteristics and multimorbidity in patients with history of stroke, myocardial infarction and their combination (hospital registry data)
2019 · E Y Okshina, M M Lukiyanov, et al. · European Heart Journal
Clinical and anamnestic characteristics and comorbidity in patients after myocardial infarction with and without arterial hypertension (data from the RECVASA-CLINIC registry)
2019 · A.N. Makoveeva, M.M. Lukyanov, et al. · Russian Journal of Preventive Medicine
Works count: 24
Citation count: 137
H-index: 7
I10-index: 5
Year
Topic
Type